Ironwood Pharmaceuticals | IRWD - Ebitda





Ebitda Cambiamento Data
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Almirall EUR 114.07M 60.37M 2025-12
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amarin USD 12.54M 28.57M 2025-06
Ardelyx USD -9.78M 19.98M 2026-06
Astellas Pharma JPY 182.02B 53.22B 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Charles River Laboratories USD 298.04M 25.1M 2026-09
Coherus Biosciences USD -43.33M 4.7M 2025-09
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Ironwood Pharmaceuticals USD 81.81M 31.71M 2025-09
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
MacroGenics USD -64.54M 34.34M 2026-06
Moderna USD -687M 571M 2026-06
Myriad Genetics USD 14.3M 4M 2025-12
Pacira USD 48.67M 8.43M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Puma Biotechnology USD 729K 11.36M 2024-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12